KLP Kapitalforvaltning’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
VPM
VCM
RRAM
KLP Kapitalforvaltning's HAE Position: Q1 2026 in Review
KLP Kapitalforvaltning increased its Haemonetics (HAE) stake by 139% in Q1 2026, buying an estimated $931K and bringing the position to 24,600 shares worth $1.39M. The position accounts for 0.01% of the portfolio, ranked #869.
KLP Kapitalforvaltning first reported a position in HAE in Q4 2024 and has held it in 6 quarters since. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- KLP Kapitalforvaltning held 24,600 shares of Haemonetics worth $1.39M as of Q1 2026.
- KLP Kapitalforvaltning bought 14,300 Haemonetics shares in Q1 2026, an estimated $931K.
- Haemonetics made up 0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #869 holding.
- KLP Kapitalforvaltning first reported a position in Haemonetics in Q4 2024 and has held it in 6 quarters since.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.